Answer
Veletri (epoprostenol sodium) is contraindicated in patients with congestive heart failure arising from severe left ventricular dysfunction.
Sources for this answer
- Veletri 1.5mg, Powder for Solution for InfusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 14Document updated
Sources checked